MPH Health Care AG: Performance Impacted but Growth Prospects Remain Strong

First Berlin Equity Research GmbH has affirmed its "Buy" recommendation for MPH Health Care AG, maintaining a target price of €37. The company's recent six-month performance was notably impacted by the significant decline in CR Energy's stock value, following the initiation of preliminary insolvency proceedings in June, resulting in an 87% drop in share price.

In contrast, M1 Kliniken AG, another core investment of MPH, continues to thrive. The specialist in lifestyle and beauty reported robust performance with earnings growth exceeding 20% year-over-year, driven by improved margins in the beauty sector. The recent AGM approved a dividend of €1.20 per share for MPH stakeholders.

Despite the CR Energy setback, the overall outlook remains promising, particularly for M1 Kliniken, with expectations of further margin enhancements due to its streamlined clinic portfolio. The "Buy" recommendation and price target suggest a potential upside of 96%.